Scotland’s First Minister Nicola Sturgeon today visited two University of Edinburgh biotechnology startups to launch a new report into women and entrepreneurship.
Researchers who have created a new tool that could transform medical understanding of inflammation – a feature of most diseases – have received £2m to test it in humans.
Blackford Analysis, a leading strategic imaging Artificial Intelligence (AI) platform and solutions provider, has announced its acquisition by Bayer, a global life science company.
This week, industry and academics got together for an Academic Industry Meeting day (AIMday) to discuss the solutions University of Edinburgh academics can offer industry in the field of living systems, biological materials and bio-engineering.
Invizius, the biotechnology spinout company developing treatments to suppress unwanted immune responses in dialysis, has been awarded a second Biomedical Catalyst grant by Innovate UK to research a new field of application for its H-Guard® technology.
Scientists at the University of Edinburgh have launched a spinout company that aims to democratise genetic data access and cut from days to minutes the time it takes to analyse millions of genetic records.
What’s your next challenge? Spin in, spin out or start up?
